NYSE: ALBAlbemarle Corp Stock
$122.59-1.19 (-0.96%)
Updated May 31, 2024
ALB Price
$122.59
Fair Value Price
N/A
Market Cap
$14.41B
52 Week Low
$106.69
52 Week High
$247.44
P/E
44.26x
P/B
1.25x
P/S
1.84x
PEG
0.36x
Dividend Yield
1.31%
Revenue
$8.40B
Earnings
$337.34M
Gross Margin
-0.6%
Operating Margin
7.31%
Profit Margin
3.9%
Debt to Equity
0.63
Operating Cash Flow
$702M
Beta
1.35
Next Earnings
Jul 31, 2024
Ex-Dividend
Jun 14, 2024
Next Dividend
Jul 1, 2024
ALB Overview
Albemarle Corporation manufactures specialty chemicals (lithium, bromine, and catalysts). Offerings based on those chemicals include butyllithium and lithium aluminum hydride, products used in fire safety solutions, fluidized catalytic cracking catalysts and additives, and performance catalyst solutions. Its customers include companies in the energy storage, petroleum refining, and consumer electronics sectors, among others. The company was founded in 1887 and is headquartered in Charlotte, NC.
Zen Score
–
Industry Average (34)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ALB scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ALB ($122.59) is trading below its intrinsic value of $135.68, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ALB is poor value based on its earnings relative to its share price (44.26x), compared to the US market average (28.44x)
P/E vs Market Valuation
ALB is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more ALB due diligence checks available for Premium users.
Be the first to know about important ALB news, forecast changes, insider trades & much more!
ALB News
Valuation
ALB price to earnings (PE)
For valuing profitable companies with steady earnings
Company
44.26x
Industry
33.33x
Market
28.44x
ALB is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
ALB is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
ALB price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.25x
Industry
3.38x
ALB is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
ALB price to earnings growth (PEG)
For valuing profitable companies with growth potential
ALB is good value based... subscribe to Premium to read more.
PEG Value Valuation
ALB's financial health
Profit margin
Revenue
$1.4B
Net Income
$2.4M
Profit Margin
-0.7%
ALB's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
ALB's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$19.0B
Liabilities
$7.2B
Debt to equity
0.63
ALB's short-term assets ($5.82B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ALB's short-term assets ($5.82B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ALB's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ALB's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$98.0M
Investing
-$494.5M
Financing
$1.6B
ALB's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
ALB vs Specialty Chemical Stocks
Albemarle Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.